Abiopharma

Samenvatting: Suzano rapporteert een aangepaste EBITDA van R$ 4,7 miljard in tweede kwartaal van 2026

Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process

Profound Medical Launches ‘Lets Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey

Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress onHemopurifier® Program

A New Press Release from Elicio Therapeutics

Herman Gerald N 🔴 sold 1.4K shares of BRUKER CORP (BRKR) at $57.02 Transaction Date: Aug 11, 2026 | Filing ID: 000003

Portney Emily Hope 🟡 adjusted position in 0 shares of MARKETAXESS HOLDINGS INC (MKTX) Transaction Date: Aug 12, 2026 | Filing ID: 349230

LAUKIEN FRANK H 🔴 sold 4.8K shares of BRUKER CORP (BRKR) at $57.02 Transaction Date: Aug 11, 2026 | Filing ID: 000003

REINEMUND STEVEN 🟢 acquired 16.1K shares of McGraw Hill, Inc. (MH) Transaction Date: Aug 11, 2026 | Filing ID: 349226

📋 JOHN KIELY (Director) plans to sell 50K shares of AMNEAL PHARMACEUTICALS, INC (at $17.59 each, total $880K) Filed: Aug 13, 2026 | ID: 056733

Chaudhuri Sarbani 🔴 sold 4.7K shares of ROCKET PHARMACEUTICALS, INC. (RCKT) at $3.50 Transaction Date: Aug 11, 2026 | Filing ID: 032816

MAS JOSE RAMON 🟡 adjusted position in 0 shares (2 derivative) of MASTEC INC (MTZ) Transaction Date: Aug 11, 2026 | Filing ID: 349225

Accel Growth Fund IV L.P. 🟡 adjusted position in 749.3K shares (3 derivative) of Ethos Technologies Inc. (LIFE) Transaction Date: Aug 11, 2026 | Filing ID: 000878

MAS JORGE 🟡 adjusted position in 0 shares (2 derivative) of MASTEC INC (MTZ) Transaction Date: Aug 11, 2026 | Filing ID: 349223

Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights